133 related articles for article (PubMed ID: 9347577)
1. Severe chronic neutropenia: pathophysiology and therapy.
Welte K; Boxer LA
Semin Hematol; 1997 Oct; 34(4):267-78. PubMed ID: 9347577
[TBL] [Abstract][Full Text] [Related]
2. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic growth factors for the treatment of severe chronic neutropenia.
Dale DC
Stem Cells; 1995 Mar; 13(2):94-100. PubMed ID: 7787781
[TBL] [Abstract][Full Text] [Related]
4. [Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia].
Zeidler C; Reiter A; Yakisan E; Koci B; Riehm H; Welte K
Klin Padiatr; 1993; 205(4):264-71. PubMed ID: 7690865
[TBL] [Abstract][Full Text] [Related]
5. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
[TBL] [Abstract][Full Text] [Related]
7. Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy.
Tidow N; Pilz C; Kasper B; Welte K
Stem Cells; 1997; 15 Suppl 1():113-9; discussion 120. PubMed ID: 9368331
[TBL] [Abstract][Full Text] [Related]
8. Alkaline phosphatase activity in neutrophils from patients with severe congenital neutropenia (Kostmann's syndrome).
Baranova K; Stanulla M; Zeidler C; Welte K
Int J Hematol; 1999 Dec; 70(4):236-40. PubMed ID: 10643149
[TBL] [Abstract][Full Text] [Related]
9. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
Donadieu J; Leblanc T; Bader Meunier B; Barkaoui M; Fenneteau O; Bertrand Y; Maier-Redelsperger M; Micheau M; Stephan JL; Phillipe N; Bordigoni P; Babin-Boilletot A; Bensaid P; Manel AM; Vilmer E; Thuret I; Blanche S; Gluckman E; Fischer A; Mechinaud F; Joly B; Lamy T; Hermine O; Cassinat B; Bellanné-Chantelot C; Chomienne C;
Haematologica; 2005 Jan; 90(1):45-53. PubMed ID: 15642668
[TBL] [Abstract][Full Text] [Related]
10. Severe congenital neutropenia.
Welte K; Zeidler C; Dale DC
Semin Hematol; 2006 Jul; 43(3):189-95. PubMed ID: 16822461
[TBL] [Abstract][Full Text] [Related]
11. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
Heussner P; Haase D; Kanz L; Fonatsch C; Welte K; Freund M
Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
[TBL] [Abstract][Full Text] [Related]
12. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and treatment of severe chronic neutropenia.
Welte K; Dale D
Ann Hematol; 1996 Apr; 72(4):158-65. PubMed ID: 8624368
[TBL] [Abstract][Full Text] [Related]
14. Congenital neutropenias.
Zeidler C; Schwinzer B; Welte K
Rev Clin Exp Hematol; 2003 Mar; 7(1):72-83. PubMed ID: 14692235
[TBL] [Abstract][Full Text] [Related]
15. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.
Beaupain B; Leblanc T; Reman O; Hermine O; Vannier JP; Suarez F; Lutz P; Bordigoni P; Jourdain A; Schoenvald M; Ouachee M; François S; Kohser F; Jardin F; Devouassoux G; Bertrand Y; Nove-Josserand R; Donadieu J;
Pediatr Blood Cancer; 2009 Dec; 53(6):1068-73. PubMed ID: 19618456
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic proteins from neutrophilic granulocytes: a comparison between patients with severe chronic neutropenia and healthy donors.
Kasper B; Thole HH; Patterson SD; Welte K
Electrophoresis; 1997 Jan; 18(1):142-9. PubMed ID: 9059836
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil growth factors.
Crawford J
Curr Hematol Rep; 2002 Nov; 1(2):95-102. PubMed ID: 12901130
[TBL] [Abstract][Full Text] [Related]
18. The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia.
Rauprich P; Kasper B; Tidow N; Welte K
Blood; 1995 Dec; 86(12):4500-5. PubMed ID: 8541539
[TBL] [Abstract][Full Text] [Related]
19. Malignant myeloid transformation in a child with severe congenital neutropenia (Kostmann's syndrome).
Chong LA; Josephine P; Ariffin H
Med J Malaysia; 2006 Jun; 61(2):236-8. PubMed ID: 16898320
[TBL] [Abstract][Full Text] [Related]
20. Pegfilgrastim in children with severe congenital neutropenia.
Fioredda F; Calvillo M; Lanciotti M; Lanza T; Giunti L; Castagnola E; Lorenzi I; Tonelli R; Ghezzi P; Dufour C
Pediatr Blood Cancer; 2010 Mar; 54(3):465-7. PubMed ID: 19927291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
